Oxford University begins COVID-19 vaccine study in children ages 6-17
In an important step towards ending the coronavirus pandemic, children at the age of 6 will be enrolled in a’s clinical study. Oxford University has started a new study to assess the safety of their in children for the first time.
In a new statement, the university says the study will assess immune responses in children ages 6-17, an age-group hitdue to school closings due to the pandemic. Around 300 volunteers are enrolled and are expected to receive their first vaccinations this month.
In the randomized, single-blind study, up to 240 participants will receive the COVID vaccine, while the control group will receive a meningitis vaccine that is safe for children and elicits a similar response.
“While most children are relatively unaffected by coronavirus and are unlikely to be uncomfortable with the infection, establishing the safety and immune response to the vaccine in children and adolescents is important as some children can benefit from vaccination,” Andrew said Pollard. the chief investigator of the legal proceedings. “These new studies will broaden our understanding of the control of SARS-CoV2 to younger age groups.”
A number of vaccines, including the globally widely used formulas Oxford-AstraZeneca and Pfizer and Moderna, have shown potent efficacy in preventing symptomatic infections. New data from Oxford earlier this month also provided the first evidence that its vaccine can not only prevent people from getting COVID-19, but also help significantly reduce its spread in the community.
The UK approved thatof the Oxford AstraZeneca vaccine in late December. The vaccine’s approval was widely celebrated because it is cheaper to manufacture and easier to transport and store than other approved vaccines. It is not currently used in the US but has been introduced in the US and elsewhere.
Researchers hope that expanding the vaccine to children will help alleviate some of the negative effects the pandemic has had on teenagers around the world.
“The COVID-19 pandemic is having profound negative effects on the education, social development and emotional well-being of children and adolescents, aside from illnesses and rare serious diseases,” said Rinn Song of the Oxford Vaccine Group. “It is therefore important to collect data on the safety and immune response to our coronavirus vaccine in these age groups so that they may benefit from being included in vaccination programs in the near future.”
Clinical studies arein the US by Pfizer and Moderna to test the safety and effectiveness of their vaccines in children. Dr. Anthony Fauci said last month he hoped American children could be vaccinated “by late spring and early summer”.